These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children. Bevan JC; Purday JP; Reimer EJ; Bevan DR Can J Anaesth; 1994 Nov; 41(11):1074-80. PubMed ID: 7828255 [TBL] [Abstract][Full Text] [Related]
5. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug. Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039 [TBL] [Abstract][Full Text] [Related]
6. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function. Cashman JN; Luke JJ; Jones RM Br J Anaesth; 1990 Feb; 64(2):186-92. PubMed ID: 2138489 [TBL] [Abstract][Full Text] [Related]
7. Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane. Goudsouzian NG; Alifimoff JK; Liu LM; Foster V; McNulty B; Savarese JJ Br J Anaesth; 1989 Mar; 62(3):263-8. PubMed ID: 2522789 [TBL] [Abstract][Full Text] [Related]
8. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Lien CA; Belmont MR; Abalos A; Eppich L; Quessy S; Abou-Donia MM; Savarese JJ Anesthesiology; 1995 May; 82(5):1131-8. PubMed ID: 7537945 [TBL] [Abstract][Full Text] [Related]
9. Comparison of neuromuscular, cardiovascular, and histamine-releasing properties of doxacurium and pipecuronium. Denman WT; Goudsouzian NG; Gelb C J Clin Anesth; 1996 Mar; 8(2):113-8. PubMed ID: 8695092 [TBL] [Abstract][Full Text] [Related]
10. Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents. Murray MJ; Coursin DB; Scuderi PE; Kamath G; Prough DS; Howard DM; Abou-Donia MA Crit Care Med; 1995 Mar; 23(3):450-8. PubMed ID: 7874894 [TBL] [Abstract][Full Text] [Related]
11. Dose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients. Koscielniak-Nielsen ZJ; Law-Min JC; Donati F; Bevan DR; Clement P; Wise R Anesth Analg; 1992 Jun; 74(6):845-50. PubMed ID: 1534472 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of doxacurium, pancuronium and vecuronium in anaesthetized patients presenting for coronary artery bypass surgery. Emmott RS; Bracey BJ; Goldhill DR; Yate PM; Flynn PJ Br J Anaesth; 1990 Oct; 65(4):480-6. PubMed ID: 1979009 [TBL] [Abstract][Full Text] [Related]
13. Train-of-four recovery after pharmacologic antagonism of pancuronium-, pipecuronium-, and doxacurium-induced neuromuscular block in anaesthetized humans. Stinson LW; Lanier WL; Lennon RL Acta Anaesthesiol Scand; 1995 Apr; 39(3):406-10. PubMed ID: 7793225 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and pharmacodynamic comparison of doxacurium and pipecuronium with pancuronium during induction of cardiac anesthesia: does the benefit justify the cost? Rathmell JP; Brooker RF; Prielipp RC; Butterworth JF; Gravlee GP Anesth Analg; 1993 Mar; 76(3):513-9. PubMed ID: 8383933 [TBL] [Abstract][Full Text] [Related]
15. Doxacurium. A review of its pharmacology and clinical potential in anaesthesia. Faulds D; Clissold SP Drugs; 1991 Oct; 42(4):673-89. PubMed ID: 1723368 [TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of doxacurium chloride. Maddineni VR; Cooper R; Stanley JC; Mirakhur RK; Clarke RS Anaesthesia; 1992 Jul; 47(7):554-7. PubMed ID: 1385680 [TBL] [Abstract][Full Text] [Related]